These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 16012909)
41. [Morphological study on brains of patients with schizophrenia--its application to the objective diagnosis]. Suzuki M; Kawasaki Y; Zhou S; Takahashi T; Kuratomo M Seishin Shinkeigaku Zasshi; 2006; 108(6):654-60. PubMed ID: 16910546 [No Abstract] [Full Text] [Related]
42. Detecting structural changes in whole brain based on nonlinear deformations-application to schizophrenia research. Gaser C; Volz HP; Kiebel S; Riehemann S; Sauer H Neuroimage; 1999 Aug; 10(2):107-13. PubMed ID: 10417245 [TBL] [Abstract][Full Text] [Related]
43. Microglial activation in a neuroinflammational animal model of schizophrenia--a pilot study. Juckel G; Manitz MP; BrĂ¼ne M; Friebe A; Heneka MT; Wolf RJ Schizophr Res; 2011 Sep; 131(1-3):96-100. PubMed ID: 21752601 [TBL] [Abstract][Full Text] [Related]
45. Characteristic microglial features in patients with hereditary diffuse leukoencephalopathy with spheroids. Tada M; Konno T; Tada M; Tezuka T; Miura T; Mezaki N; Okazaki K; Arakawa M; Itoh K; Yamamoto T; Yokoo H; Yoshikura N; Ishihara K; Horie M; Takebayashi H; Toyoshima Y; Naito M; Onodera O; Nishizawa M; Takahashi H; Ikeuchi T; Kakita A Ann Neurol; 2016 Oct; 80(4):554-65. PubMed ID: 27490250 [TBL] [Abstract][Full Text] [Related]
46. Increased macrophages and changed brain endothelial cell gene expression in the frontal cortex of people with schizophrenia displaying inflammation. Cai HQ; Catts VS; Webster MJ; Galletly C; Liu D; O'Donnell M; Weickert TW; Weickert CS Mol Psychiatry; 2020 Apr; 25(4):761-775. PubMed ID: 30214039 [TBL] [Abstract][Full Text] [Related]
47. Social signalling and schizophrenia: the significance of neurochemical and morphological abnormalities of the basolateral circuit. Deakin JF; Simpson MD; Slater P; Royston MC Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():495A-497A. PubMed ID: 1386782 [No Abstract] [Full Text] [Related]
48. Temporal-lobe length is reduced, and gyral folding is increased in schizophrenia: a post-mortem study. Highley JR; Esiri MM; McDonald B; Cooper SJ; Crow TJ Schizophr Res; 1998 Nov; 34(1-2):1-12. PubMed ID: 9824872 [TBL] [Abstract][Full Text] [Related]
49. Immune involvement in the pathogenesis of schizophrenia: a meta-analysis on postmortem brain studies. van Kesteren CF; Gremmels H; de Witte LD; Hol EM; Van Gool AR; Falkai PG; Kahn RS; Sommer IE Transl Psychiatry; 2017 Mar; 7(3):e1075. PubMed ID: 28350400 [TBL] [Abstract][Full Text] [Related]
50. Microglia activation in postmortem brains with schizophrenia demonstrates distinct morphological changes between brain regions. Gober R; Ardalan M; Shiadeh SMJ; Duque L; Garamszegi SP; Ascona M; Barreda A; Sun X; Mallard C; Vontell RT Brain Pathol; 2022 Jan; 32(1):e13003. PubMed ID: 34297453 [TBL] [Abstract][Full Text] [Related]
51. Evidence for activation of microglia in patients with psychiatric illnesses. Bayer TA; Buslei R; Havas L; Falkai P Neurosci Lett; 1999 Aug; 271(2):126-8. PubMed ID: 10477118 [TBL] [Abstract][Full Text] [Related]
52. Lipid Pathology of the Corpus Callosum in Schizophrenia and the Potential Role of Abnormal Gene Regulatory Networks with Reduced Microglial Marker Expression. Shimamoto-Mitsuyama C; Nakaya A; Esaki K; Balan S; Iwayama Y; Ohnishi T; Maekawa M; Toyota T; Dean B; Yoshikawa T Cereb Cortex; 2021 Jan; 31(1):448-462. PubMed ID: 32924060 [TBL] [Abstract][Full Text] [Related]
53. Microglia in the cerebral cortex in autism. Tetreault NA; Hakeem AY; Jiang S; Williams BA; Allman E; Wold BJ; Allman JM J Autism Dev Disord; 2012 Dec; 42(12):2569-84. PubMed ID: 22466688 [TBL] [Abstract][Full Text] [Related]
54. The pro-apoptotic ARTS/Sept4 protein is significantly reduced in post-mortem brains from schizophrenic patients. Gottfried Y; Rotem A; Klein E; Larisch S Schizophr Res; 2007 Nov; 96(1-3):257-66. PubMed ID: 17644312 [TBL] [Abstract][Full Text] [Related]
55. Prenatal developmental disturbances in the limbic allocortex in schizophrenics. Jakob H; Beckmann H J Neural Transm; 1986; 65(3-4):303-26. PubMed ID: 3711886 [TBL] [Abstract][Full Text] [Related]
56. Microglial contribution to synaptic uptake in the prefrontal cortex in schizophrenia. Tzioras M; Stevenson AJ; Boche D; Spires-Jones TL Neuropathol Appl Neurobiol; 2021 Feb; 47(2):346-351. PubMed ID: 32892388 [TBL] [Abstract][Full Text] [Related]
57. Problems of interpretation in the chemical pathology of schizophrenia. Pope A J Psychiatr Res; 1974; 11():265-72. PubMed ID: 4461795 [No Abstract] [Full Text] [Related]
58. Microglia and microbiome in schizophrenia: can immunomodulation improve symptoms? Juckel G; Freund N J Neural Transm (Vienna); 2023 Sep; 130(9):1187-1193. PubMed ID: 36810627 [TBL] [Abstract][Full Text] [Related]
59. [Quantitative studies on relative cell and cell nucleus volumina in clinically normal persons and schizophrenics]. TREFF WM; HEMPEL KJ J Hirnforsch; 1959; 4():412-54. PubMed ID: 13839247 [No Abstract] [Full Text] [Related]
60. Some pathological findings in schizophrenics. HOWIE DL Am J Psychiatry; 1960 Jul; 117():59-62. PubMed ID: 14403505 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]